In Clinical Trials, New Drug for Sickle-Cell Disease Shows Promise

vcuA new compound developed by a team of researchers at the Institute for Structural Biology and Drug Discovery, a joint effort of the School of Medicine and the School of Pharmacy at Virginia Commonwealth University, offers hope for sufferers of sickle cell disease.

The compound, originally patented by Virginia Commonwealth University, was licensed to AesRx, a biopharmaceutical company that develops experimental drugs. AesRx was recently purchased by Baxter International, on the world’s leading pharmaceutical companies. The drug is now in Phase 2 clinical trials and early results show that the drug can be effective in reducing the sickling of red blood cells and therefore improve blood flow in patients.

This potential new treatment for sickle-cell disease is of particular interest to the African American community. While people of any race can have the sickle-cell trait, the disease is far more common among African Americans than it is among Whites. About one in every 400 African Americans is born with the sickle-cell trait.

Related Articles

Leave a Reply

Get the JBHE Weekly Bulletin

Receive our weekly email newsletter delivered to your inbox

Latest News

Online Articles That May Be of Interest to JBHE Readers

Each week, JBHE will provide links to online articles that may be of interest to our readers. Here are this week’s selections.

Recent Books of Interest to African American Scholars

The Journal of Blacks in Higher Education regularly publishes a list of new books that may be of interest to our readers. The books included are on a wide variety of subjects and present many different points of view.

Higher Education Gifts or Grants of Interest to African Americans

Here is this week’s news of grants or gifts to historically Black colleges and universities or for programs of particular interest to African Americans in higher education.

In Memoriam: Wendell Harris, 1940-2024

Throughout his career in education, Harris served in a wide variety of settings including K-12 schools, community colleges, and universities. He also spent several years as an administrator with the New York Department of Education.

Featured Jobs